Coordonnées
Centre de recherche – CHUM
Institut du cancer de Montréal
T 514 890-8000 #25496
F 514 412-7703
Anne-Marie.Mes-Masson@umontreal.ca
Axe de recherche
- Cancérologie
- Génomique
Description de la recherche
- Développement d’un modèle de tumeurs pour étudier le cancer
- Banques de tissus et cultures/lignées cellulaires primaires
- Cancer de l’ovaire, cancer de la prostate et cancer du sein
- Analyse à haut débit pour découvrir les événements génétiques et épigénétiques dans l’initiation et la progression tumorale
- Oncologie moléculaire et recherche translationnelle
Research axis
- Cancer
- Genomic
Research description
- Development of tumor models to study cancer
- Tissue banks and derived primary cultures/cell lines
- Ovarian cancer, prostate cancer and breast cancer
- High throughput analysis to uncover genetic and epigenetic events in tumor initiation and progression
- Molecular oncology and translational research
Publications
- Ouellet, V., Guyot, M.-C., Le Page, C., Filali-Mouhim, A., Provencher, D., Lussier, C., Tonin, P.N., and Mes-Masson, A.-M. 2006. Tissue array validation of microarray candidates identifies new molecular markers that correlated with tumor grade and outcomes in serous epithelial ovarian cancer. Int. J. Cancer 119 (3): 599-607.
- Péant, B., Diallo, J.-S., Le Page, C., Dufour, F., Delvoye, N., Saad, F., and Mes-Masson, A.-M. 2009. Over-expression of IkB-Kinase-e (IKKe) induces secretion of inflammatory cytokines in prostate cancer cell lines. The Prostate. 69(7): 706-718.
- Madore, J., Ren, F., Filai-Mouhim, A., Sanchez, L., Köbel, M., Tonin, P.N., Hunstman, D., Provencher, D., and Mes-Masson, A.-M. 2010. Characterization of the molecular divergence of ovarian endometrioid carcinoma and ovarian serous carcinoma. J. Path. 220(3): 392-400.
- Barrès, V., Ouellet, V., Lafontaine, J., Tonin, P.N., Provencher, D., and Mes-Masson, A-M. 2010. An essential role for Ran GTPase in epithelial ovarian caner cell survival. Mol. Cancer 9(1): 272
- Koumakpayi, I.H., Le Page, C., Delvoye, N., Saad, F., and Mes-Masson, A.-M. 2011. Marcopinotysis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells. Mol. Carcinog. 50(11): 901-912.